In fact, STAT5 activation is crucial for cancer progression in chronic myelogenous leukemia (CML) and myeloproliferative disease induced by TEL–JAK2 (9, 10). The gene discussed is JAK2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.